Ekso Bionics Holdings IncNASDAQ:EKSO
- LAST PRICE1.7400
- TODAY'S CHANGE (%)0.0400 (2.3529%)
- Bid / Lots1.7100/ 1
- Ask / Lots1.7500/ 2
- Open / Previous Close1.7000 / 1.7000
- Day Range
- 52 Week Range
- Volume6,688
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EKSO |
|---|---|---|
| 09:32 ET | 1315 | 1.7 |
| 09:42 ET | 268 | 1.71 |
| 09:46 ET | 100 | 1.72 |
| 09:48 ET | 4185 | 1.71 |
| 10:11 ET | 200 | 1.72 |
| 10:27 ET | 273 | 1.71 |
| 10:47 ET | 100 | 1.74 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ekso Bionics Holdings Inc | 22.3M | -1.5x | --- |
Precipio Inc | 21.6M | -1.8x | --- |
Avinger Inc | 10.6M | -0.3x | --- |
HTG Molecular Diagnostics Inc | 11.7M | -0.2x | --- |
LogicMark Inc | 4.9M | -0.2x | --- |
Escalon Medical Corp | 444.9K | -0.7x | --- |
Company Information
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products that augment human strength, endurance and mobility. The Company’s exoskeleton technology serves multiple markets and can be utilized both by able-bodied users and persons with physical disabilities. The Company operates in two segments: EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform repetitive work. Its products include EksoNR and EksoUE. EksoNR is a rehabilitation device that assists physical therapists and physicians to treat patients who have suffered an acquired brain injury, stroke or spinal cord injury. EksoUE is a wearable upper body exoskeleton that assists patients with a broad range of upper extremity impairments.
Contact Information
- Headquarters
- 101 GLACIER POINT, SUITE ASAN RAFAEL, CA, United States 94901
- Phone
- 510-984-1761
- Fax
- 702-866-2689
Executives
- Executive Chairman of the Board
- Steven Sherman
- Chief Executive Officer, Director
- Scott Davis
- Chief Financial Officer, Corporate Secretary
- Jerome Wong
- Vice President - Product Development
- Jason Jones
- Lead Independent Director
- Stanley Stern
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $22.3M |
|---|---|
Revenue (TTM) | $13.4M |
Shares Outstanding | 13.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.72 |
EPS | $-1.18 |
Book Value | $2.93 |
P/E Ratio | -1.5x |
Price/Sales (TTM) | 1.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -116.63% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
